New delayed-release stimulant improves morning ADHD symptoms and all-day functioning

September 25, 2017, Mary Ann Liebert, Inc
Credit: Mary Ann Liebert, Inc., publishers

A phase 3 study of children ages 6-12 years with attention deficit/hyperactivity disorder (ADHD) has shown that a delayed-release, long-acting formulation of the stimulant methylphenidate, when taken in the evening, led to significant improvement in ADHD symptoms and functional impairment first thing the next morning, compared to a placebo. Children taking the delayed-release stimulant did not have to wait for a morning dose to take effect and also benefited from improved symptoms later in the afternoon and evening, according to the study results published in Journal of Child and Adolescent Psychopharmacology.

The article entitled "Efficacy and Safety of HLD200, Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder" is coauthored by Steven Pliszka, MD, from The University of Texas Health Science Center at San Antonio and colleagues from Massachusetts General Hospital (Boston, MA), Westside Medical Family Practice (Clinton, UT), University of Tennessee Health Science Center (Memphis, TN), Meridien Research (Maitland and Bradenton, FL), Children's Development Center (Winter Park, FL), Ironshore Pharmaceuticals & Development (Grand Cayman, Cayman Islands), and Mount Sinai Medical Center (New York, NY), on behalf of the HLD200-108 Study Group.

The drug formulation, which consists of two layers of microbeads with an inner drug-loaded core, delays release of the active ingredient for 8-10 hours and then provides controlled extended release designed to cover the early morning into the evening. The medication was well tolerated, with the main adverse effects of appetite suppression and insomnia being those commonly reported for other formulations of methylphenidate.

"Developing new formulations of effective medications for patients with ADHD improves the lives of children with the disorder," says Harold S. Koplewicz, MD, Editor-in-Chief of the Journal of Child and Adolescent Psychopharmacology and President of the Child Mind Institute in New York.

Explore further: Is extended-release guanfacine effective in children with chronic tic disorders?

More information: Steven R. Pliszka et al, Efficacy and Safety of HLD200, Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder, Journal of Child and Adolescent Psychopharmacology (2017). DOI: 10.1089/cap.2017.0084

Related Stories

Is extended-release guanfacine effective in children with chronic tic disorders?

July 26, 2017
A new study assessed the safety, tolerability, and effectiveness of extended-release guanfacine in children 6-17 years of age who have chronic tic disorders including Tourette's disorder. Researchers designed the randomized ...

Guanfacine is safe and well-tolerated in children and adolescents with anxiety disorder

March 1, 2017
A pilot study of guanfacine, a controlled-release alpha2-agonist, in children and adolescents with general, separation-related, and social anxiety disorder showed the drug to be safe and well-tolerated and provided preliminary ...

Atomoxetine improves critical reading skills in children with dyslexia

September 7, 2016
A new study shows significant improvement in critical components of reading, including decoding and vocabulary, among children treated with atomoxetine compared to placebo. Atomoxetine treatment was also associated with significant ...

Psychostimulants more likely to reduce rather than worsen anxiety in children with ADHD

October 6, 2015
A new review of studies involving nearly 3,000 children with attention deficit/hyperactivity disorder (ADHD) concludes that, although anxiety has been reported as a side-effect of stimulant medication, psychostimulant treatment ...

Five-fold increase in ADHD medication use in children and adolescents

September 10, 2013
Use of stimulant medications to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adolescents has increased significantly over the past several years. This trend toward increased use of prescription stimulants ...

Does psychostimulant use increase cardiovascular risk in children with ADHD?

June 26, 2014
Psychostimulant use to treat children and adolescents with attention-deficit/hyperactivity disorder (ADHD) is increasing worldwide, and the evaluation of the cardiovascular safety of stimulant medication used in treatment ...

Recommended for you

Kids with severe brain injuries may develop ADHD: study

March 19, 2018
(HealthDay)—Young children who sustain a severe head injury may struggle with attention problems as they grow older, researchers say.

For children with ADHD, a brief, school-based program can help dramatically with homework problems, study finds

December 6, 2017
Children with attention deficit hyperactivity disorder who took part in a brief, school-based program displayed significant improvements in their homework, organization and planning skills, according to a new study led by ...

What can twitter reveal about people with ADHD?

November 9, 2017
What can Twitter reveal about people with attention-deficit/hyperactivity disorder, or ADHD? Quite a bit about what life is like for someone with the condition, according to findings published by University of Pennsylvania ...

Brain imaging reveals ADHD as a collection of different disorders

November 8, 2017
Researchers have found that patients with different types of attention-deficit/hyperactivity disorder (ADHD) have impairments in unique brain systems, indicating that there may not be a one-size-fits-all explanation for the ...

Can adults develop ADHD? New research says probably not

October 20, 2017
Adults likely do not develop ADHD, according to new research by FIU clinical psychologist Margaret Sibley.

Nearly a third of college kids think ADHD meds boost grades

October 16, 2017
(HealthDay)—Many college students who abuse ADHD drugs mistakenly believe that doing so will lead to better grades, a new survey suggests.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.